Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP369919.RAflFcHxanJ2aFp6YmBFWT7xw2vbKfWtkOKmx9fany0fI130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369919.RAflFcHxanJ2aFp6YmBFWT7xw2vbKfWtkOKmx9fany0fI130_provenance.
• NP466287.RARN1BUqoqRBos4O6A-PIgbLZtp0TlZ9HOEEhEMppbKMI130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466287.RARN1BUqoqRBos4O6A-PIgbLZtp0TlZ9HOEEhEMppbKMI130_provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP239167.RA0wALS0jK0iJY9b69YltIrx2bbw53TlF2vx1IGvgfiHA130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239167.RA0wALS0jK0iJY9b69YltIrx2bbw53TlF2vx1IGvgfiHA130_provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP567037.RAR8t4haz0oGhvaN4rd86rKW9r_lvIVJfT13KKFQqIL20130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567037.RAR8t4haz0oGhvaN4rd86rKW9r_lvIVJfT13KKFQqIL20130_provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP567025.RAhIuTsOZpyQCKVk5Ytjus2-NXih0kjupnEZaf0eZ21Ek130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567025.RAhIuTsOZpyQCKVk5Ytjus2-NXih0kjupnEZaf0eZ21Ek130_provenance.
• NP827600.RAdiGee1iKDnBBtc0vudx48toBbi3AhcXxfZfaJWnupfo130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827600.RAdiGee1iKDnBBtc0vudx48toBbi3AhcXxfZfaJWnupfo130_provenance.
• NP827606.RAWqAbJdpCDFiAN06j4Mj6cwm2aQGR1tLTWHEhJhHV0ZU130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827606.RAWqAbJdpCDFiAN06j4Mj6cwm2aQGR1tLTWHEhJhHV0ZU130_provenance.
• NP827607.RAeEIcgqY0zAewEQZ_lMI-C3vQyXfU8pKmo1BdM05umnE130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827607.RAeEIcgqY0zAewEQZ_lMI-C3vQyXfU8pKmo1BdM05umnE130_provenance.
• NP373845.RAsbZrt72nF6rU371wA3dLNfRhsft941tDz5ehHdc0N7M130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373845.RAsbZrt72nF6rU371wA3dLNfRhsft941tDz5ehHdc0N7M130_provenance.
• NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
• NP422012.RAtp2Iu0bKDBUiK0yWRDbRbYHfwm9DrL2G2O1XycbVio8130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422012.RAtp2Iu0bKDBUiK0yWRDbRbYHfwm9DrL2G2O1XycbVio8130_provenance.
• NP827609.RAgZjcp_yNsCfKwSl3eQIuPOylgHH_bLSgPbDwHsMDq8U130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827609.RAgZjcp_yNsCfKwSl3eQIuPOylgHH_bLSgPbDwHsMDq8U130_provenance.
• NP422009.RAIFxvXKFOX6f3h_xajRSjjh_AJukTlrZ-O7y8WpImQd8130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422009.RAIFxvXKFOX6f3h_xajRSjjh_AJukTlrZ-O7y8WpImQd8130_provenance.
• NP827610.RAGltGULzsPFg6p9ZRGkcfMaOoqOndZsAcNKjotErr3Vc130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827610.RAGltGULzsPFg6p9ZRGkcfMaOoqOndZsAcNKjotErr3Vc130_provenance.
• NP827602.RAwU-V5gp-Aolr4N38OuATxblxs6ddjUxHmS4wr9FasFA130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827602.RAwU-V5gp-Aolr4N38OuATxblxs6ddjUxHmS4wr9FasFA130_provenance.